Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cultivarium develops open-source tools and protocols to enable scientists to culture, genetically engineer, and study non-model microorganisms—including bacteria, fungi, archaea, and protists. Their work has enabled genetic tool development in over 300 previously unengineered microbes. The organization’s efforts are accelerating discovery in medicine, sustainable agriculture, climate solutions, and biomanufacturing by making more of the microbial world accessible to scientific inquiry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Le Cultivarium.